Glaukos to Showcase Technologies at 2024 AAO Annual Meeting in Chicago
Glaukos announced that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, October 18-21, 2024, in Chicago.
Glaukos is also sponsoring an educational symposium in conjunction with EyeWorld and AAO entitled, “iDose TR: The Gateway to Interventional Glaucoma” on Saturday, October 19, 2024, at 7:00-8:00 am CT in the Grand Horizon EF Ballroom at the Marriott Marquis McCormick Place. The faculty includes Ike Ahmed, MD; John Berdahl, MD; Nathan Radcliffe, MD; Deborah Ristvedt, DO; and Savak Teymoorian, MD. Go here for more information and to register.
Key Glaucoma Posters:
- John Berdahl, MD
Effect of Travoprost Intracameral Implant in Eyes with Prior Failed Selective Laser Trabeculoplasty (SLT) - Mohammed ElMallah, MD
Travoprost Intracameral Implant (iDose TR) Delivers Therapeutic Aqueous Humor Drug Levels and Lowers IOP Over 24 Months - Ali Salimi, MD
A Decade-Long Outcome of Two First-Generation Trabecular Micro-Bypass Stents with Cataract Surgery in POAG
Key Corneal Health Presentations:
- 2:15-2:45 p.m., Weijie Lin, MD
Risk Factors for Complications After CXL for KCN
Abstract information can be found at www.aao.org/annual-meeting.
Glaukos will be exhibiting onsite at booth #2608.